WDFC NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

WD-40 Company · Basic Materials · Specialty Chemicals

Open interactive chart View report data Download investor PDF
Latest close 231.3 USD
-6.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.7% above the Trend Line and sits at 46.5% of its 52-week range. The latest completed week returned -6.3%, after a -6.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 44/100 conviction, while the latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 84d.

Setup score 42 out of 100
Latest Close 231.3 USD 24 Jul 2026
1W Return -6.3% latest completed week
4W Return -6.5% short-term follow-through
12W Return 9.6% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 40.78% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.3% Latest completed week; four-week move -6.5%. Indicator stack 36/95 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.78% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 44/100 conviction; expected move 6.7%. News sentiment 60/100 28 relevant articles in the latest sentiment read. Event risk 84d Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.7% above the Trend Line and sits at 46.5% of its 52-week range. The latest completed week returned -6.3%, after a -6.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.39

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.5% over four weeks, 9.6% over 12 weeks, and 11.6% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-6.3%
4W-6.5%
12W9.6%
26W8.0%
52W11.6%
Active trend streak5 weeks
Active weeks in one year18
Trend breadth34.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change342.1%Four-week change in activity pressure.
Leadership-0.55Latest relative-leadership reading.
RS change-126.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Aug 2025 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality88/100Profitability and accounting quality. Underlying universe rank 13; rank 1 is best.
Momentum66/100Medium-term price momentum. Underlying universe rank 35; rank 1 is best.
Growth33/100Revenue and earnings growth. Underlying universe rank 68; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework42/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
34.8x
Price divided by trailing earnings.
Price / sales
4.6x
Market value relative to trailing revenue.
EV / EBITDA
24.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
55.8%
Gross profit retained from each unit of revenue.
Operating margin
17.5%
Operating profit retained from revenue.
Free-cash-flow margin
13.3%
Free cash flow generated from revenue.
Return on invested capital
27.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.2%
Latest one-year revenue growth.
EPS growth
3.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
0.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.7%
Cash dividends relative to market value.
Buyback yield
0.8%
Net share repurchases relative to market value.
Shareholder yield
2.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

WDFC shows bullish options pressure with a 44/100 conviction score, put-call volume ratio of 0.14, expected move of 6.7%, and Sharemaestro trend signal active.

Conviction44/100
Expected move6.7%
Put/call volume0.14
Pressure80
Speculation8
Volatility50
Trend agreement15
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 28 relevant articles.

13 positive · 12 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 21 Oct 2026; event risk rises as the date approaches.
Options expected move6.7%Nearest-chain priced movement where available.
52-week drawdown-22.3%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+9.3%Week of 26 Jun.
Worst week-6.5%Week of 17 Jul.
Latest week-6.3%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains8
Flat weeks0
Modest losses7
Sharp losses6
Recent vol5.5%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis42/100

Latest 12-week confirmation: trend 6/12, activity pressure 5/12, relative leadership 4/12.

Activity pressure 0.57; 2 reversal markers Next-Week ExpectancyNegative 40.78%

Next-week expectancy is negative with a 40.78% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 32; Small Cap Core rank 95 SVQF42/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 418.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options48/100

WDFC shows bullish options pressure with a 44/100 conviction score, put-call volume ratio of 0.14, expected move of 6.7%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 6.7% Sentiment60/100

Weighted news tone is neutral across 28 relevant articles.

WD-40 Company Revenue Breakdown – DUS:WD1 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings84d

Next report is scheduled for 21 Oct 2026; event risk rises as the date approaches.

 Research flow1 items

0 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026231.3 USD-6.3%221.0 USD225.8 USD0.97-0.55646.5KOn
17 Jul 2026246.8 USD-6.5%220.0 USD225.7 USD1.214.23866.7KOn
10 Jul 2026263.8 USD7.8%218.5 USD225.5 USD1.076.621.9MOn
3 Jul 2026244.8 USD-1.0%216.4 USD225.2 USD0.700.54584.2KOn
26 Jun 2026247.3 USD9.3%214.5 USD224.8 USD0.222.04976.3KOn
19 Jun 2026226.3 USD1.9%212.8 USD224.3 USD-0.39-11.14714.9KOff
12 Jun 2026222.1 USD9.2%211.8 USD224.0 USD-0.69-11.12904.3KOff
5 Jun 2026203.4 USD1.7%210.9 USD223.8 USD-1.00-17.38668.5KOff
29 May 2026200.0 USD-3.5%210.7 USD223.7 USD-0.97-23.14623.4KOff
22 May 2026207.3 USD2.9%210.4 USD223.6 USD-0.85-18.86723.1KOff
15 May 2026201.4 USD-3.2%210.2 USD223.4 USD-0.59-20.98653.6KOff
8 May 2026208.1 USD-1.4%209.9 USD223.3 USD-0.31-19.40694.6KOn
1 May 2026211.1 USD-6.2%209.3 USD223.2 USD-0.08-14.53744.7KOn
24 Apr 2026225.0 USD5.4%208.6 USD222.9 USD-0.02-8.241.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.